1971
DOI: 10.1016/s0140-6736(71)90804-x
|View full text |Cite
|
Sign up to set email alerts
|

B.C.G. Vaccination and Leukæmia Mortality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

1974
1974
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 6 publications
0
17
0
Order By: Relevance
“…Before its computerization in 2010, the Québec BCG Registry had been used in research on tuberculosis [13,16,17], leukaemia [18,19], type 1 diabetes [20], and asthma [21]. Although data from this registry can be useful in various epidemiological study designs, their most efficient utilization will be through linkage with existing provincial medical administrative health databases.…”
Section: Discussionmentioning
confidence: 99%
“…Before its computerization in 2010, the Québec BCG Registry had been used in research on tuberculosis [13,16,17], leukaemia [18,19], type 1 diabetes [20], and asthma [21]. Although data from this registry can be useful in various epidemiological study designs, their most efficient utilization will be through linkage with existing provincial medical administrative health databases.…”
Section: Discussionmentioning
confidence: 99%
“…Studies focussing on BCG vaccination and cancer are summarized in Table 3. In the early 1970s, a decreased leukaemia mortality rate among individuals who had received neonatal BCG vaccination was reported (100, 101). This report triggered several reactions in the scientific community: some criticizing the methods (102, 103), others cautiously presenting somewhat convergent results (104, 105).…”
Section: Cancermentioning
confidence: 99%
“…Encouraged by these results, Israel 8?-84 conducted additional trials for squamous carcinoma of the lung, oat cell carcinoma of the lung, breast cancer, and soft tissue sarcomas. The results are presented in TABLE 9. For all tumor types, patients treated with C. parvum plus chemotherapy survived longer than did patients treated with chemotherapy alone.…”
Section: Systemic Chemoimmunotherapymentioning
confidence: 99%